does retatrutide affect liver Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic liver disease (MASLD), formerly fatty liver disease. This Substack Series 3 of 6:

This article explores the exciting potential of GLP-1 Drugs in tackling a range of obesity-related illnesses, promising a future where these drugs become cornerstones of a healthier world

Avoidance of sugar-sweetened beverages has been shown to decrease adiposity in children and may benefit children with overweight or obesity who have MASLD [80,81]

Key takeaways There are no FDA-approved generic versions of many GLP-1 drugs, including Ozempic, Wegovy, Mounjaro, or Zepbound

Its certainly the new GLP-1 economy, as we call it, says Dr

These medications mimic the action of a hormone called glucagon-like peptide-1 (GLP-1), which is naturally released after eating to regulate blood sugar and control appetite